<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097183</url>
  </required_header>
  <id_info>
    <org_study_id>ICICOR-ACA-2021</org_study_id>
    <nct_id>NCT05097183</nct_id>
  </id_info>
  <brief_title>Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation</brief_title>
  <acronym>ACA</acronym>
  <official_title>Clinical Validation and Prognostic Evaluation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ignacio J. Amat Santos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clínico Universitario de Valladolid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Transcatheter aortic valve replacement (TAVR) has become the preferred therapy&#xD;
      for aortic stenosis. Given the growing life-expectancy, the risk of requiring coronary&#xD;
      interventions or of developing prosthesis degeneration that could require TAVR-in-TAVR for&#xD;
      its treatment progressively increases. During standard TAVI procedures the native and the&#xD;
      prosthesis commissures are randomly aligned with misalignment in up to 70% of the cases. This&#xD;
      might hinder coronary re-access in 18% of the cases, increase the risk of coronary&#xD;
      obstruction during future TAVR-in-TAVR procedures, and has been associated to greater&#xD;
      residual gradients.&#xD;
&#xD;
      Methods: Although several techniques have been developed to increase the degree of&#xD;
      commissural alignment, all are imperfect or imply manipulation of the system within the&#xD;
      patient, potentially increasing the risk of complications. The research team developed a&#xD;
      software based on computed tomography analysis that allows planification of accurate&#xD;
      commissural alignment by inserting the delivery system in a patient-specific degree of&#xD;
      rotation.&#xD;
&#xD;
      Aim: The proponent team aimed to prospectively validate this methodology comparing a cohort&#xD;
      of patients harboring TAVR with Acurate Commissural Alignment (ACA) vs. a control cohort with&#xD;
      non-ACA standard technique, in order to determine benefits in terms of coronary re-access and&#xD;
      clinical events (coronary events, valve degeneration, and TAVR-in-TAVR).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Degree of commissural alignment</measure>
    <time_frame>6 months</time_frame>
    <description>Mean minimum angular deviation between TAVR posts and aortic valve commissures measured in CT-scan</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Successful coronary re-access</measure>
    <time_frame>10 minutes, right after TAVR</time_frame>
    <description>Coronary re-access was successful or not after TAVR implant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of leaflet thrombosis</measure>
    <time_frame>6 months</time_frame>
    <description>Presence of clinical/subclinical leaflets thrombosis assessed by CT-Scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Residual transvalvular gradients</measure>
    <time_frame>24 months</time_frame>
    <description>Residual transvalvular gradients measured in transthoracic echocardiography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Severe Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Transcatheter aortic valve replacement (TAVR) with standard procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACA</arm_group_label>
    <description>Transcatheter aortic valve replacement (TAVR) with Accurate Commissural Alignment (ACA) technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Accurate Commissural Alignment (ACA)</intervention_name>
    <description>Software based, computed tomography analysis that allows planification of accurate commissural alignment of TAVR by inserting the delivery system in a patient-specific degree of rotation.</description>
    <arm_group_label>ACA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with severe aortic stenosis admitted to TAVR by Heart Team and&#xD;
        fulfilling inclusion criteria in 16 centers in Spain. The Sponsor is proctoring the new ACA&#xD;
        technique in this centers. TAVR patients treated both with standard and ACA technique will&#xD;
        be included in the registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with severe aortic stenosis admitted to TAVR by Heart Team&#xD;
&#xD;
          -  Pre-procedure CT-Scan for planning available.&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergic to contrast&#xD;
&#xD;
          -  Severe renal failure (GFR &lt; 30 mL/min)&#xD;
&#xD;
          -  Indication for chronic anticoagulation&#xD;
&#xD;
          -  Horizontal aorta and/or severe aortic tortuosity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ignacio J Amat-Santos, PhD</last_name>
    <phone>983420000</phone>
    <phone_ext>86571</phone_ext>
    <email>icicor@icicor.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos Baladrón, PhD</last_name>
    <phone>983420000</phone>
    <phone_ext>86571</phone_ext>
    <email>icicor@icicor.es</email>
  </overall_contact_backup>
  <reference>
    <citation>Redondo A, Valencia-Serrano F, Santos-Martínez S, Delgado-Arana JR, Barrero A, Serrador A, Gutiérrez H, Sánchez-Lite I, Sevilla T, Revilla A, Baladrón C, Kim WK, Carrasco-Moraleja M, San Román JA, Amat-Santos IJ. Accurate commissural alignment during ACURATE neo TAVI procedure. Proof of concept. Rev Esp Cardiol (Engl Ed). 2021 Mar 26. pii: S1885-5857(21)00068-2. doi: 10.1016/j.rec.2021.02.004. [Epub ahead of print] English, Spanish.</citation>
    <PMID>33781722</PMID>
  </reference>
  <reference>
    <citation>Redondo A, Santos-Martínez S, Delgado-Arana R, Baladrón Zorita C, San Román JA, Amat-Santos IJ. Fluoroscopic-based algorithm for commissural alignment assessment after transcatheter aortic valve implantation. Rev Esp Cardiol (Engl Ed). 2021 Sep 29. pii: S1885-5857(21)00260-7. doi: 10.1016/j.rec.2021.08.010. [Epub ahead of print] English, Spanish.</citation>
    <PMID>34600863</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clínico Universitario de Valladolid</investigator_affiliation>
    <investigator_full_name>Ignacio J. Amat Santos</investigator_full_name>
    <investigator_title>Coordinator of Interventional Cardiology Unit</investigator_title>
  </responsible_party>
  <keyword>Transcatheter aortic valve replacement (TAVR)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

